NeoProfen recalled

Lundbeck Inc. has recalled two lots of NeoProfen (ibuprofen lysine) that failed to meet a visible particulate quality requirement. NeoProfen is used to close a clinically significant patent ductus arteriosus (PDA) in premature infants. Read more here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

covid-19 virus illustration

Will Omicron Be More Contagious Than Delta?

If the first thing you heard about the omicron variant over the holiday weekend was that it is bad news, the second thing was...